Global Clinical Trials (GCT), a leading contract research organization (CRO), has taken a step in strengthening our clinical trial auditing services with the inclusion of an exceptionally experienced European auditor. Dmitry Vorobiev – MD, PhD, MRQA is a seasoned professional that brings a wealth of knowledge and expertise, having conducted over 470 audits throughout his distinguished career in the industry.

With a meticulous eye for detail and an extensive understanding of international regulatory frameworks, Dmitry will play a pivotal role in conducting thorough assessments of clinical trial processes and documentation. His wealth of experience will prove invaluable in identifying potential areas of improvement and ensuring adherence to the highest standards of data integrity.

Dr. Eugene Selivra, Chief Executive Officer at GCT, expressed his delight at having this esteemed auditor join our team, stating, “We are thrilled to welcome such a distinguished expert on board. Their vast experience and unparalleled insight into auditing processes will undoubtedly elevate the quality and reliability of our auditing services. This addition aligns perfectly with GCT’s commitment to delivering excellence in clinical research.”

Dmitry’s presence further solidifies GCT’s dedication to providing cutting-edge solutions to their clients, reinforcing the company’s position as a trusted partner in the development of life-changing therapies. As the demand for transparent and compliant clinical trials continues to grow, GCT’s inclusion of such an experienced auditor in their team positions them as a prominent force in ensuring the integrity of clinical trial data.

For further information about GCT’s clinical trial auditing services and their comprehensive range of service offerings, please visit our official website or contact our business development team.